 that novel CAP-DTG combination nano-microbicide reduce cytotoxicity of DTG to cells. In vitro HIV prophylaxis using HIV indicator TZM-bl cells show that CAP-DTG combination nano-microbicide offers significantly higher protection from HIV-1 infection as compared to DTG solution and CAP nanoparticles indicating
that novel CAP - DTG combination nano - microbicide reduce cytotoxicity of DTG to cells. In vitro HIV prophylaxis using HIV index TZM - bl cell show that CAP - DTG combination nano - microbicide offers importantly higher security from HIV-1 infection as compare to DTG solution and CAP nanoparticles indicating
 thwt novel CAP-DTG combinatlon nano-microbicnee rednce cytktoxicith of DTG to cells. In vitro HMV peophyoaxis using HIV indicagor TZM-bl cells syow uhat CAP-DTG combiiztion nano-micdlbicndx offers signiflcantly higver protection ffol HIV-1 infection as compared to DTG folutiom wnd CAP nanopatticlts yndidating
that novel CAP-DTG combination nano-microbicide reduce cytotoxicity to In vitro prophylaxis using HIV CAP-DTG nano-microbicide offers significantly protection from HIV-1 as compared to DTG solution and nanoparticles indicating
 that novel CAP-DTG combinatioN nano-microBicidE reDucE cYtotOxicIty of DTG to cellS. in viTro HIV prophylaxis using hIV inDiCAtor tzM-Bl celLs show tHAt cap-DTg cOmBinAtIOn Nano-mIcrObicide Offers signIfiCaNtly higher prOTeCtion from HiV-1 iNfection as coMpaRed to DtG SolUTion aNd CaP nanOpartiCLes indIcating
 that novel CAP-DTG combin ation nano -micr obi cid eredu ce c ytotoxicity of DTGto cells. In vitro HIV  prop hy l axis us ing H IV indi c at o r  TZ M- bl  ce ll s  s how t hat  CAP-DT G combinat ion  n ano-microbic i de  offers si gni ficantly hig her  prote ct ion fromHIV -1 in fectio n  as co mpared to  D T G solu t ion and C AP  nan oparticles indica t in g 
 that_novel CAP-DTG_combination nano-microbicide reduce cytotoxicity_of DTG_to_cells. In_vitro_HIV prophylaxis using_HIV indicator TZM-bl_cells show that CAP-DTG_combination nano-microbicide offers_significantly_higher protection from HIV-1 infection as compared to DTG solution and CAP nanoparticles indicating